ALM-412 is under clinical development by Almirall and currently in Phase I for Familial Adenomatous Polyposis.

Diagnosis: Familial adenomatous polyposis with mental retardation, caused by an interstitial deletion of the long arm of chromosome 5 encompassing the APC (adenomatous polyposis coli) tumor ...

A free fatty acid form of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) reduces both the size and number of polyps in patients with familial adenomatous polyposis (FAP ...

Have you been diagnosed with Adrenal tumour? Here are the top 10 signs that will help you know if its cancerous or not!

Patients with the inherited, autosomal-dominant disorder, familial adenomatous polyposis (FAP) characteristically develop numerous colorectal adenomas during adolescence, and suffer from ...

Patients with conditions like inflammatory bowel disease may need to limit antigen-rich foods, while those with familial ...

The rights come with $17M in non-dilutive funding for a pivotal Phase 3 study of the drug in the treatment of Familial Adenomatous Polyposis, or FAP, a genetic orphan disease that can cause ...

This procedure is commonly used to treat ulcerative colitis, Crohn's disease, and familial adenomatous polyposis. It is often done in a minimally invasive fashion which involves the use of small ...

Ladenburg raised the firm’s price target on Biodexa Pharmaceuticals (BDRX) to $18 from $8 and keeps a Buy rating on the shares. The company ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...